CHS INC — fact timeline

CHS INC reported second quarter of fiscal year 2026 ended February 28, 2026 results: revenue $8.4 billion, net income $147.1 million.

“CHS Inc., a global agribusiness and the nation’s leading cooperative, today released results for its second quarter of fiscal year 2026. The company reported a net loss of $147.1 million and revenues of $8.4 billion for the quarter that ended February 28, 2026, compared to a net loss of $75.8 million and revenues of $7.8 billion in the second quarter of fiscal year 2025.”

CHS INC amended credit facility of $200 million to $250 million with Coöperatieve Rabobank U.A., New York Branch maturing August 26, 2026.

“The Omnibus Amendment extends the scheduled term of the Company’s repurchase financing facility under the Framework Agreement to August 26, 2026 and increases the Funding Limit (as defined in the Framework Agreement) from $200 million to $250 million.”

CHS INC amended credit facility with MUFG Bank, Ltd. maturing August 26, 2026.

“The Receivables Purchase Agreement Amendment further amends and restates the Receivables Purchase Agreement to add BBVA via joinder to the Receivables Purchase Agreement and other Transaction Documents as a Committed Purchaser (as defined in the Receivables Purchase Agreement) and a Purchaser Agent (as defined in the Receivables Purchase Agreement) and extend the term of the Company’s receivables and loans securitization facility provided under the Receivables Purchase Agreement to August 26, 2026, unless terminated earlier pursuant to the terms of the Receivables Purchase Agreement.”

CHS INC incurred senior notes of $250,000,000 with the accredited investors signatory thereto (collectively, the "Purchasers") at 6.13% maturing July 16, 2039.

“(iv) Series GG Notes in the aggregate principal amount of $250,000,000 with a maturity date of July 16, 2039 (the “Series GG Notes" together with the Series DD Notes, the Series EE Notes and the Series FF Notes, the “Notes")”

CHS INC incurred senior notes of $150,000,000 with the accredited investors signatory thereto (collectively, the "Purchasers") at 6.05% maturing July 16, 2037.

“(iii) Series FF Notes in the aggregate principal amount of $150,000,000 with a maturity date of July 16, 2037 (the “Series FF Notes")”

CHS INC incurred senior notes of $150,000,000 with the accredited investors signatory thereto (collectively, the "Purchasers") at 5.93% maturing July 16, 2034.

“(ii) Series EE Notes in the aggregate principal amount of $150,000,000 with a maturity date of July 16, 2034 (the “Series EE Notes")”

CHS INC incurred senior notes of $150,000,000 with the accredited investors signatory thereto (collectively, the "Purchasers") at 5.84% maturing July 16, 2032.

“On April 18, 2024, CHS Inc. (the “Company”) entered into a Note Purchase Agreement (the “Note Purchase Agreement”) with the accredited investors signatory thereto (collectively, the “Purchasers”), pursuant to which the Company will issue and sell, in a private placement, its, (i) Series DD Notes in the aggregate principal amount of $150,000,000 with a maturity date of July 16, 2032 (the “Series DD Notes")”

CHS INC entered into Note Purchase Agreement with the accredited investors signatory thereto (collectively, the "Purchasers") valued at $700,000,000 (effective 2024-04-18).

“On April 18, 2024, CHS Inc. (the “Company”) entered into a Note Purchase Agreement (the “Note Purchase Agreement”) with the accredited investors signatory thereto (collectively, the “Purchasers”), pursuant to which the Company will issue and sell, in a private placement, its, (i) Series DD Notes in the aggregate principal amount of $150,000,000 with a maturity date of July 16, 2032 (the “Series DD Notes”), (ii) Series EE Notes in the aggregate principal amount of $150,000,000 with a maturity date of July 16, 2034 (the “Series EE Notes”), (iii) Series FF Notes in the aggregate principal amount of $150,000,000 with a maturity date of July 16, 2037 (the “Series FF Notes”) and (iv) Series GG Notes in the aggregate principal amount of $250,000,000 with a maturity date of July 16, 2039 (the “Series GG Notes” together with the Series DD Notes, the Series EE Notes and the Series FF Notes, the “Notes”).”

CHS INC reported financial results for its quarter ended February 29, 2024.

“On April 3, 2024, CHS Inc. issued a press release announcing its results of operations for its quarter ended February 29, 2024. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.”